Insider Trading activities at Mbx Biosciences, Inc. (MBX)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Mbx Biosciences, Inc. (MBX) since 2024 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Mbx Biosciences, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1776111.

Total stock buying since 2024: $138,600,855.
Total stock sales since 2024: $0.
Total stock option exercises since 2024: $0.


17 insiders reported insider trading activities at Mbx Biosciences, Inc. (MBX):
Insider trading activities of Mathers Edward T
Insider trading activities of Makhzoumi Mohamad
Insider trading activities of Topper James N
Insider trading activities of Hawryluk P. Kent
Insider trading activities of Gordon Carl L
Insider trading activities of Behbahani Ali
Insider trading activities of Orbimed Genesis Gp Llc
Insider trading activities of Yang Rick
Insider trading activities of Baskett Forest
Insider trading activities of Chang Carmen
Insider trading activities of Florence Anthony A. Jr.
Insider trading activities of Pescovitz Ora H.
Insider trading activities of Aynechi Tiba
Insider trading activities of Heron Patrick J
Insider trading activities of Sandell Scott D
Insider trading activities of Walker Paul Edward
Insider trading activities of Nea 17 Gp, Llc

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Mbx Biosciences, Inc. (MBX).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 248,365 $2,600,855 0 $0 0 $0
2024 8,500,000 $136,000,000 0 $0 0 $0

Table 2. Monthly summary of insider trading at Mbx Biosciences, Inc. (MBX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2025-04 7,693 $45,311 0 $0 0 $0
2025-02 240,672 $2,555,544 0 $0 0 $0
2024-09 8,500,000 $136,000,000 0 $0 0 $0

Table 3. Detailed insider trading at Mbx Biosciences, Inc. (MBX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2025-04-08 Pescovitz Ora H. Buy 7,693 5.89 45,311
2025-02-18 Orbimed Genesis Gp Llc Buy 143,170 10.84 1,551,962
2025-02-14 Orbimed Genesis Gp Llc Buy 47,502 9.88 469,082
2025-02-04 Hawryluk P. Kent (President & CEO) Buy 50,000 10.69 534,500
2024-09-16 Yang Rick Buy 500,000 16.00 8,000,000
2024-09-16 Orbimed Genesis Gp Llc Buy 750,000 16.00 12,000,000
2024-09-16 Nea 17 Gp, Llc Buy 500,000 16.00 8,000,000
2024-09-16 Chang Carmen Buy 500,000 16.00 8,000,000
2024-09-16 Aynechi Tiba Buy 750,000 16.00 12,000,000
2024-09-16 Makhzoumi Mohamad Buy 500,000 16.00 8,000,000
2024-09-16 Behbahani Ali Buy 500,000 16.00 8,000,000
2024-09-16 Florence Anthony A. Jr. Buy 500,000 16.00 8,000,000
2024-09-16 Walker Paul Edward Buy 500,000 16.00 8,000,000
2024-09-16 Heron Patrick J Buy 625,000 16.00 10,000,000
2024-09-16 Topper James N Buy 625,000 16.00 10,000,000
2024-09-16 Mathers Edward T Buy 500,000 16.00 8,000,000
2024-09-16 Gordon Carl L Buy 750,000 16.00 12,000,000
2024-09-16 Baskett Forest Buy 500,000 16.00 8,000,000
2024-09-16 Sandell Scott D Buy 500,000 16.00 8,000,000

Insider trading activities including stock purchases, stock sales, and option exercises of MBX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Mbx Biosciences, Inc. (symbol MBX, CIK number 1776111) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.